SCOPE 2024: Key Takeaways From A First-Time Attendee

By Darcy Grabenstein

This author recently attended the SCOPE conference for the first time and was overwhelmed by the sheer number of sessions covering a wide range of topics in clinical trials. As noted in her article below, the conference emphasized the importance of quality data in driving innovation and the need for accountability in its use, as well as diversity in clinical trials, and patient-centricity.

Overall, the author found the SCOPE conference to be a fulfilling experience. However, they've commented that they may need a year to process and digest the information before attending again. Learn more about what the author appreciated about the event and how she's planning to apply the knowledge gained in her work.